BSECompany UpdateResults30 Jul 2026
Aimco Pesticides Ltd
Newspaper Publications informing the shareholders regarding the special window for re-lodgement of transfer requests of physical shares.
Aimco Pesticides Ltd has announced a special window for re-lodgement of transfer requests of physical shares that were lodged prior to April 1, 2019 and rejected/returned due to deficiencies in the documents. The company has published a notice in newspapers and made it available on its website. The SEBI circular is also available on the company's website.
BSECompany Update▲ PositiveResults30 Jul 2026
Apcotex Industries Ltd
Please find enclosed Earning Presentation - June 2026 (Q1 - FY 2026-27)
Apcotex Industries Ltd has released its Q1-FY27 earnings presentation, showcasing a 40% year-on-year growth in revenue from operations, driven by higher price realisations despite lower sales volumes. The company delivered its strongest quarterly financial performance with the highest-ever EBITDA, PBT, and PAT in its history. However, export volumes were impacted by geopolitical tensions in West Asia and resulting logistics disruptions.
BSECompany Update▲ PositiveResults30 Jul 2026
Vedanta Power Ltd
Newspaper Publication
Vedanta Power Ltd has published unaudited financial results for the first quarter ended June 30, 2026, with net profit for the period after tax at Rs 140.83 crore, up from Rs 597.73 crore in the same quarter last year.
BSECompany UpdateResults30 Jul 2026
PNGS Reva Diamond Jewellery Ltd
Copies of Unaudited Financial Results published in newspapers - ''Financial Express'' and ''Loksatta'' on July 30, 2026 are enclosed herewith.
PNGS Reva Diamond Jewellery Ltd has published its unaudited financial results for the quarter ended June 30, 2026, in newspapers 'Financial Express' and 'Loksatta' on July 30, 2026.
BSEBoard MeetingResults30 Jul 2026
Gillette India Ltd
Gillette India Limited has informed the exchange about the Outcome of the Board Meeting held on July 30, 2026
Gillette India Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹78,302 lakhs and profit before tax at ₹21,402 lakhs.
BSECompany UpdateResults30 Jul 2026
Paradeep Phosphates Ltd
Enclosed extract of statement of unaudited financial results of the Company for the quarter ended June 30, 2026
Paradeep Phosphates Ltd has announced the enclosed extract of statement of unaudited financial results for the quarter ended June 30, 2026, published in Business Line and The Samaja on July 30, 2026. The company's scrip code in BSE is 543530 and its symbol in NSE is PARADEEP.
BSECompany Update▲ PositiveResults30 Jul 2026
eMudhra Ltd
Earnings Presentation on the financial results of the company for the quarter ended June 30, 2026
eMudhra Ltd has announced its Q1 FY2027 financial results, with revenue growth of 27.8% YoY and EBITDA growth of 40.4% YoY. The company's adjusted EBITDA margin improved to 27.5% and adjusted PAT margin to 17.6%. The company's business overview highlights its three lines of business: trust services, enterprise solutions, and services, with a focus on AI trust and governance.
BSECompany UpdateResults30 Jul 2026
JTL Defence Ltd
Investor Presentation for the quarter ended June 30, 2026
JTL Defence Ltd has released its Q1 FY27 earnings presentation, highlighting revenue growth, expansion plans, and operational improvements.
BSECompany UpdateResults30 Jul 2026
eMudhra Ltd
Newspaper Advertisement of the unaudited financial results of the company for the quarter ended June 30, 2026
eMudhra Ltd publishes unaudited financial results for Q1 FY2027, available on its website and in newspapers.
BSEOthersResults30 Jul 2026
Suven Life Sciences Ltd
Annual Report 2025-26 and Notice of 37th Annual General Meeting (AGM) of the Company
Suven Life Sciences Ltd has announced its Annual Report 2025-26 and Notice of 37th Annual General Meeting (AGM) scheduled to be held on August 25, 2026. The report reveals a widened revenue growth, increased R&D investment, and a net loss. The company has completed Phase 3 studies for several molecules, including Masupirdine, Samelisant, and Tenaclidine, and has initiated Phase 2 clinical trials for others.
BSECompany Update▲ PositiveResults30 Jul 2026
Hester Biosciences Ltd
20260730 Q1 FY27 Press Release
Hester Biosciences Ltd announced its unaudited financial results for Q1 FY27, with standalone revenue up 14% and profit up 88%, and consolidated revenue down 8% and profit up 459% due to an exceptional gain from the amendment of the Gates Foundation loan.
BSEBoard MeetingResults30 Jul 2026
Polyspin Exports Ltd
Polyspin Exports Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the Unaudited Standalone and ....
Polyspin Exports Ltd has scheduled a board meeting on August 13, 2026, to consider the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
BSECompany UpdateResults30 Jul 2026
V-Guard Industries Ltd
Newspaper publication of Unaudited Financial results for the quarter ended June 30 2026.
V-Guard Industries Ltd has published unaudited financial results for the quarter ended June 30, 2026, with the results available on the company's website.
BSECompany Update▲ PositiveResults30 Jul 2026
JTL Defence Ltd
Earnings Release for the quarter ended June 30, 2026
JTL Defence Ltd reported a 39.4% QoQ increase in revenue from operations to Rs. 212 Mn in Q1 FY27, driven by improved business operations. EBITDA was Rs. 25 Mn with a margin of 11.6%, and adjusted PAT was Rs. 1 Mn, excluding additional depreciation of Rs. 28 Mn on revalued assets.
BSEBoard MeetingResults30 Jul 2026
Fine Organic Industries Ltd
Fine Organic Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Financial Results for ....
Fine Organic Industries Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 to consider and approve Financial Results for the quarter ended June 30, 2026.
BSECompany UpdateResults30 Jul 2026
Triveni Glass Ltd-$
The unaudited financial results for june 2026 are published in two newspapers today i.e on 30.07.2026
Triveni Glass Ltd has published its unaudited financial results for the quarter ended June 30, 2026, in two newspapers on July 30, 2026.
BSECompany UpdateResults30 Jul 2026
Triveni Glass Ltd-$
The unaudited financial results for the quarter ended 30.06.2026 are published in two newspapers on 30.07.2026 .
Triveni Glass Ltd published unaudited financial results for the quarter ended 30.06.2026 in two newspapers on 30.07.2026.
BSEBoard MeetingResults30 Jul 2026
Krishanveer Forge Ltd
Krishanveer Forge Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
Krishanveer Forge Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 05/08/2026 to consider and approve Unaudited Financial Results for the Quarter ended June 30, 2026, and to fix the Record Date for determining the entitlement to Dividend for the Financial Year 2025-26.
BSEResult▲ PositiveResults30 Jul 2026
Hester Biosciences Ltd
Financial Results and Press Release for the Quarter ended 30 June 2026
Hester Biosciences Ltd has announced its financial results for the quarter ended 30 June 2026, with a profit of INR 147.11 crore and a total comprehensive income of INR 147.11 crore. The company's revenue from operations was INR 726.60 crore, with a segment-wise revenue of INR 18.16 crore from Poultry Healthcare and INR 108.44 crore from Animal Healthcare. The company's segment results were INR 236.72 crore, with a profit before tax of INR 197.52 crore.
BSECompany UpdateResults30 Jul 2026
Zensar Technologies Ltd
Audio Recording of Q1FY27 Results Earnings Call held on July 30, 2026
Zensar Technologies Ltd has made available the audio recording of its Q1FY27 earnings call held on July 30, 2026, on its website under the Investors Corner section.